Description
Developer of next generation gene expression systems designed to solve problems in molecular therapeutics. The company's gene expression systems are developed with genetically engineered CHO cells and also provides services like gene cloning, codon optimization, gene synthesis, cell culture scale up, cell based assays and fow cytometry, enabling physicians to kill cancer cells with the highest possible efficiencies while leaving normal cells unharmed.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Out of Business | 01-Aug-2016 | 00000 | Completed | Out of Business | ||
4. Grant | 04-Nov-2010 | 00000 | Completed | Startup | ||
3. Early Stage VC | 16-Dec-2009 | 00000 | Completed | Startup | ||
2. Early Stage VC | 01-Apr-2009 | $237K | Completed | Startup | ||
1. Accelerator/Incubator | 09-Jul-2008 | $237K | $237K | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ja Koo Ph.D | Co-Founder & Chief Technology Officer |